Evidence map›Paper›PMID 31303374›Full record

ArticleNeuron2019

A Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation.

Damon Polioudakis, Luis de la Torre-Ubieta, Justin Langerman, Andrew G Elkins, Xu Shi, Jason L Stein, Celine K Vuong, Susanne Nichterwitz, Melinda Gevorgian, Carli K Opland and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 308 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
308citing papers in PubMed, 4 pooled it
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

308 citing papers in PubMed, 4 syntheses or guidelines pooled it, 559 citations in OpenAlex.

  1. Pooled it
  2. Variable expression ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

248 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Damon PolioudakisDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Luis de la Torre-UbietaDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Justin LangermanDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Andrew G ElkinsDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Xu ShiProgram in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.
Jason L SteinDepartment of Genetics & UNC Neuroscience Center, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA.
Celine K VuongDepartment of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Susanne NichterwitzDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Melinda GevorgianDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Biology, CSUN, Northridge, CA, USA.
Carli K OplandDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Daning LuDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
William ConnellDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Elizabeth K RuzzoDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Jennifer K LoweDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Tarik HadzicDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Flora I HinzDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Shan SabriDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
William E LowryDepartment of Molecular, Cell and Developmental Biology, UCLA, Los Angeles, CA, USA.
Mark B GersteinProgram in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA; Department of Computer Science, Yale University, New Haven, CT 06520, USA; Department of Statistics and Data Science, Yale University, New Haven, CT 06520, USA.
Kathrin PlathDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Daniel H GeschwindDepartment of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Center for Autism Research and Treatment, Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. Electronic address: dhg@mednet.ucla.edu.
University of California, Los Angeles · USYale University · USCalifornia State University, Northridge · USCenter for Autism and Related Disorders · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Autism Genetics, Phase II: Increasing Representation of Human DiversityR01MH100027 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GESCHWIND, DANIEL H · 2013 to 2024
$31.7M
Roles of sumoylation and alternative polyadenylation in cellular reprogrammingP01GM099134 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PLATH, KATHRIN · 2011 to 2021
$20.3M
A Comprehensive Approach to Identification of Autism Susceptibility GenesR01MH081754 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GESCHWIND, DANIEL H · 2008 to 2012
$14.6M
TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
2/2-Discovery and validation of neuronal enhancers associated with the development of psychiatric disordersU01MH116489 · NIMH · UNIVERSITY OF CHICAGO · PI GAYNOR, SOPHIA, GESCHWIND, DANIEL H · 2018 to 2022
$4.5M
2/3 Integrative Genomic Analysis of Human Brain Development and AutismR01MH110927 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GESCHWIND, DANIEL H · 2016 to 2019
$2.7M
Defining cell types, lineage, and connectivity in developing human fetal cortexU01MH105991 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GESCHWIND, DANIEL H · 2014 to 2016
$2.0M
Genetic Influences on Human Cortical DevelopmentR00MH102357 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STEIN, JASON LOUIS · 2016 to 2018
$747k
NCI NIH HHS T32 CA009056NIAID NIH HHS P30 AI028697NIGMS NIH HHS P01 GM099134NIMH NIH HHS R00 MH102357NIMH NIH HHS R01 MH081754NIMH NIH HHS R01 MH100027NIMH NIH HHS R01 MH110927NIMH NIH HHS U01 MH105991NIMH NIH HHS U01 MH116489
6 · The paper itself

Abstract

We performed RNA sequencing on 40,000 cells to create a high-resolution single-cell gene expression atlas of developing human cortex, providing the first single-cell characterization of previously uncharacterized cell types, including human subplate neurons, comparisons with bulk tissue, and systematic analyses of technical factors. These data permit deconvolution of regulatory networks connecting regulatory elements and transcriptional drivers to single-cell gene expression programs, significantly extending our understanding of human neurogenesis, cortical evolution, and the cellular basis of neuropsychiatric disease. We tie cell-cycle progression with early cell fate decisions during neurogenesis, demonstrating that differentiation occurs on a transcriptomic continuum; rather than only expressing a few transcription factors that drive cell fates, differentiating cells express broad, mixed cell-type transcriptomes before telophase. By mapping neuropsychiatric disease genes to cell types, we implicate dysregulation of specific cell types in ASD, ID, and epilepsy. We developed CoDEx, an online portal to facilitate data access and browsing.

Indexed as

Databases, GeneticGene Expression Regulation, DevelopmentalAutism Spectrum DisorderCell CycleCerebral CortexEpendymoglial CellsEpilepsyFemaleGene Expression ProfilingGene Regulatory NetworksGestational AgeHumansIntellectual DisabilityInterneuronsNeocortexNeural Stem Cellsautismcortical developmentdifferentiationepilepsyevolutionhumanintellectual disabilityneurogenesisschizophreniasubplate

Identifiers

PMID31303374
PMCPMC6831089
OpenAlexW2958746550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.